The Bladder Outlet-Cancer Score (BOCS) As a prognostic tool for therapy-response in bladder cancer patients
Main Authors: | L. Di Gianfrancesco, M. Ragonese, G. Palermo, E. Sacco, D. Nigro, A. Distante, A. Totaro, N. Foschi, P. Bassi, M. Racioppi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320355981 |
Similar Items
-
A new prognostic tool for therapy-response in non-muscle invasive bladder cancer patients: The Bladder Outlet-Cancer Score (BOCS)
by: L. Di Gianfrancesco, et al.
Published: (2020-11-01) -
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
by: Marco Racioppi, et al. -
The diagnostic accuracy of Bladder EpiCheck in high-risk population
by: M. Racioppi, et al.
Published: (2020-07-01) -
Improved non-invasive diagnosis of Bladder Cancer: A large pilot study with electronic nose
by: P.F. Bassi, et al.
Published: (2020-01-01) -
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes
by: Marco Racioppi, et al.
Published: (2018-12-01)